Focus Partners Wealth
AURA icon

Focus Partners Wealth’s Aura Biosciences AURA Stock Holding History

Focus Partners Wealth’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,049
Closed -$71.3K – 2812
2026
Q2 		$71.3K Buy
+10,049
New +$71.9K ﹤0.01% 2657

Other funds holding AURA

Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Regency Capital Management
Regency Capital Management Honolulu, Hawaii $247M AUM 24.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Focus Partners Wealth's AURA Position: Q3 2026 in Review

Focus Partners Wealth sold out of Aura Biosciences (AURA) in Q3 2026, closing a stake of 10,049 shares — an estimated $71.3K sold.

Focus Partners Wealth first reported a position in AURA in Q2 2026 and held it in 1 quarter. The position peaked at $71.3K in Q2 2026. 77 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Focus Partners Wealth reported no remaining Aura Biosciences position as of Q3 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 10,049 Aura Biosciences shares in Q3 2026, an estimated $71.3K.
  • Focus Partners Wealth first reported a position in Aura Biosciences in Q2 2026 and held it in 1 quarter.
  • Focus Partners Wealth's Aura Biosciences position peaked at $71.3K in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.